Health and wellness products company Herbalife (NYSE:HLF) will be reporting earnings tomorrow after the bell. Here's what to look for.
Last quarter Herbalife reported revenues of $1.28 billion, down 1.1% year on year, beating analyst revenue expectations by 2.3%. It was a weak quarter for the company, with a miss of analysts' EPS estimates.
Is Herbalife buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting Herbalife's revenue to grow 0.6% year on year to $1.19 billion, improving on the 10.4% year-over-year decline in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.39 per share.
The analysts covering the company have been growing increasingly bullish about the business heading into the earnings, with revenue estimates seeing two upward revisions over the last thirty days. The company missed Wall St's revenue estimates three times over the last two years.
Looking at Herbalife's peers in the personal care segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. e.l.f. delivered top-line growth of 84.9% year on year, beating analyst estimates by 13.4% and Coty (NYSE:COTY) reported revenues up 13.4% year on year, exceeding estimates by 2.9%. e.l.f. traded up 1.7% on the results, and Coty was down 1.6%.
Read the full analysis of e.l.f.'s and Coty's results on StockStory.
Investors in the personal care segment have had steady hands going into the earnings, with the stocks up on average 1.7% over the last month. Herbalife is up 1.4% during the same time, and is heading into the earnings with analyst price target of $17.3, compared to share price of $12.7.
